Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • KRE vs GSK✓SelectedUSD · GSKKRE vs GSK performance historyLatest closeAs of+0.30%11/13
Stock and ETF performance explorer

KRE vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+148.6%
GSK return
+151.6%
Excess return
-3.0%
Maximum drawdown
-68.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.3%+0.5%-0.2%0.0%
7D+0.7%+1.1%-0.4%+0.2%
30D+6.1%+6.3%-0.2%+2.8%
3M-5.9%+1.8%-7.7%-7.3%
6M+9.6%+1.7%+7.9%+7.5%
YTD+14.2%+6.5%+7.6%+8.5%
1Y+22.5%+9.5%+13.0%+14.6%
3Y+90.4%+65.3%+25.1%+34.3%
5Y+11.9%+43.7%-31.9%-16.8%
10Y+88.8%+104.1%-15.3%+6.7%
All+148.6%+151.6%-3.0%+1.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling